Nutrition, Microbiome and Immunity
The Nutrition, Microbiome and Immunity Group is a dynamic and international team with expertise in microbiology, immunology, molecular genetics, public health, and bioinformatics.
activities
Our research focuses on understanding how our changing dietary habits, especially the reduced consumption of dietary fiber, impacts susceptibility to various diseases such as inflammatory bowel diseases, multiple sclerosis and allergy, as well as to a variety of gastrointestinal pathogens. We investigate the microbiome-mediated molecular mechanisms that impact our immune system via the interaction with the colonic mucus barrier, which is one of the first lines of host defense. In order to effectively address our research questions, we utilise a variety of tools and techniques from high-throughput culturing of commensal gut bacteria to next-generation sequencing, as well as immunological tools like mass cytometry (CyTOF).
Our research exploits the power of synthetic human gut microbiotas in various gnotobiotic mouse models of the multiple diseases. Importantly, we also incorporate translational approaches to shift findings from a mouse model to human cohorts in order to inform clinical care or public health measures related to dietary fiber intake and disease.
The mission of our research is to pursue the “from bed to bench to bed” approach to explore the disease-based biomarkers and susceptibility factors that could be used as critical transition points between health and disease in order to harness the potential of microbiome engineering.
Desai
Partners
Projects & clinical trials
Featured team members
Scientific publications
-
Dietary fibers boost gut microbiota-produced B vitamin pool and alter host immune landscape – 01/12/2024
-
Metabolite-based inter-kingdom communication controls intestinal tissue recovery following chemotherapeutic injury – 11/09/2024
-
Gut microbial factors predict disease severity in a mouse model of multiple sclerosis – 15/07/2024
-
The Absence of Gastrointestinal Redox Dyshomeostasis in the Brain-First Rat Model of Parkinson’s Disease Induced by Bilateral Intrastriatal 6-Hydroxydopamine – 01/01/2024
-
Non-SCFA microbial metabolites associated with fiber fermentation and host health – 01/01/2024
-
Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility – 01/01/2024
-
Akkermansia muciniphila and Parabacteroides distasonis synergistically protect from colitis by promoting ILC3 in the gut – 10/04/2024
-
Opposing diet, microbiome, and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host – 01/01/2024
-
Multicomponent (bio)markers for obesity risk prediction – 08/03/2024
-
Low dose dietary contamination with deoxynivalenol mycotoxin exacerbates enteritis and colorectal cancer in mice – 22/07/2023
Related News
Job vacancies
-
Post-Doctoral Fellow: Gut microbiome and mucosal immunology (JA/PDGMMI0424/MD/DII)
Department of Infection & Immunity – Nutrition, Microbiome & Immunity unit